SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-18-007827
Filing Date
2018-11-09
Accepted
2018-11-09 11:47:07
Documents
3
Effectiveness Date
2018-11-09

Document Format Files

Seq Description Document Type Size
1 FORM S-8 fs8_110818.htm S-8 58862
2 EXHIBIT 5.1 exh_51.htm EX-5.1 7260
3 EXHIBIT 23.1 exh_231.htm EX-23.1 2074
  Complete submission text file 0001171843-18-007827.txt   69233
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228296 | Film No.: 181171974
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1